SEC Form 4 · accession 0000905718-15-000604
CANCER GENETICS, INC · CGIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rita Shaknovich
Officer — VP of Hematopathology Services
Period of report
Jul 8, 2015
Accepted (ET)
Jul 13, 2015 · 5:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001349929
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per shareF1 | Jul 8, 2015 | A | 3,000 | $0.00 | A | 3,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $11.36 | Jul 8, 2015 | A | 12,000 | A | Sep 28, 2015 | Jul 8, 2025 | Common Stock, par value $0.0001 per share | 12,000 | 12,000 | D |
Explanation of responses
- F1The restricted stock underlying the award vests in three equal installments on June 15, 2016, June 15, 2017 and June 15, 2018, respectively.
- F2The option vests in forty-eight equal monthly installments commencing on September 28, 2015.